Article Details
Retrieved on: 2022-06-29 16:03:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... HER2-positive breast cancer who have received 1 or more prior anti-HER2-based regimens, according to a press release from AstraZeneca.1.
Article found on: www.cancernetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here